Please find a floor map here.

Poster number C186: In vitro profiling and Compare Analysis of the novel HDAC6 selective inhibitor ST80 in 42 human tumor cell lines

Gerhard Kelter1, Thomas Metz1, Stolfa Diana2, Manfred Jung2, Heinz-Herbert Fiebig1. 1Oncotest GmbH, Institute for Experimental Oncology, Freiburg, Germany; 2Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany

Poster number B113: Establishment of a clinically relevant orthotopic xenograft model for human liver cancer

Kerstin Klingner, Torsten Giesemann, Steffen Baltes, Heinz Herbert Fiebig, Julia B. Schueler. Oncotest GmbH, Freiburg, Germany

Poster number C110: Mutation and chemosensitivity profile of a panel of 25 patient-derived melanoma xenografts*

Heinz Herbert Fiebig, Vincent Vuaroqueaux, Armin Maier, Gerhard Kelter, Julia Schueler, Rebekka Krumbach. Oncotest GmbH, Freiburg, Germany

Poster number A231: Combination of MET and EGFR inhibitors in patient-derived tumor xenografts

Rebekka Krumbach, Armin Maier, Nina Baltes, Steffen Baltes, Heinz H. Fiebig. Oncotest GmbH, Freiburg, Germany

Poster number B177: PTEN/PTENP1 transcripts expression and alterations in a large panel of human tumor xenograft in nude mice: Implication for resistance to targeted therapies involving EGFR/ PI3K/PTEN pathways

Vincent Vuaroqueaux1, Andreas Ackermann2, Rebekka Krumbach2, Hanns-Christian

Tillmann3, Frederic Foucault1, Julia Schuler2, Thomas Metz2, Heinz-Herbert Fiebig2. 1Oncotest AG, Riehen, Switzerland; 2Oncotest GmbH, Freiburg, Germany; 3Focus IP GmbH, Riehen, Switzerland

Poster number  A52: The use of Oncotest molecular database to identify amplified and over-expressed drug target genes

Frederic Foucault1, Rebekka Krumbach2, Thomas Metz2, Heinz-Herbert Fiebig2, Vincent

Vuaroqueaux1. 1Oncotest AG, Riehen, Switzerland; 2Oncotest GmbH, Freiburg, Germany

 *selected for a press release